The biotechnology industry is weathering the financial crisis better than some. That doesn't mean it's in great shape, reports Heidi Ledford.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
For more of Nature's coverage on how the recession affects science, see our special
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. Biotechs feel the pain. Nature 457, 136–137 (2009). https://doi.org/10.1038/457136a
Published:
Issue Date:
DOI: https://doi.org/10.1038/457136a
